Oesophageal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 80 years old
- People who have been diagnosed with esophageal squamous cell carcinoma (a specific type of oesophageal cancer) confirmed by a pathology test, at clinical stage II to IVA
- People who have received pre-surgery treatment combining chemotherapy and immunotherapy
- People whose general physical functioning is rated 0 or 1 on a standard medical scale (meaning they are fully active or have only mild limitations in physical activity) (confirm with trial site)
Who may not be able to join:
- People whose expected survival time is estimated to be less than 6 months
- People whose cancer had already spread to distant parts of the body at the time of their first diagnosis
- People who have had another cancer, or a cancer-related condition, within the past 5 years
- People who are pregnant or trying to become pregnant
- People who are considered part of a vulnerable group, including those unable to give informed consent, minors, people without a fixed address, students of researchers involved in the trial, or employees connected to the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 86+153 2712 2084
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Tumor diameter
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.